These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8187239

  • 1. Lipoprotein(a) and coronary heart disease.
    Rodriguez CR, Seman LJ, Ordovas JM, Jenner J, Genest MS, Wilson PW, Schaefer EJ.
    Chem Phys Lipids; 1994 Jan; 67-68():389-98. PubMed ID: 8187239
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
    Kraft HG, Lingenhel A, Köchl S, Hoppichler F, Kronenberg F, Abe A, Mühlberger V, Schönitzer D, Utermann G.
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):713-9. PubMed ID: 8640397
    [Abstract] [Full Text] [Related]

  • 3. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
    Kalina A, Császár A, Füst G, Nagy B, Szalai C, Karádi I, Duba J, Prohászka Z, Horváth L, Dieplinger H.
    Clin Chim Acta; 2001 Jul 05; 309(1):45-51. PubMed ID: 11408005
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D.
    Nutr Metab Cardiovasc Dis; 2004 Aug 05; 14(4):193-9. PubMed ID: 15553596
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease.
    Geethanjali FS, Luthra K, Lingenhel A, Kanagasaba-Pathy AS, Jacob J, Srivastava LM, Vasisht S, Kraft HG, Utermann G.
    Atherosclerosis; 2003 Jul 05; 169(1):121-30. PubMed ID: 12860258
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein (a): perspectives from a lipid-referral program.
    Rubenfire M, Vodnala D, Krishnan SM, Bard RL, Jackson EA, Giacherio D, Brook RD.
    J Clin Lipidol; 2012 Jul 05; 6(1):66-73. PubMed ID: 22264576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease.
    Katsouras CS, Karabina SA, Tambaki AP, Goudevenos JA, Michalis LK, Tsironis LD, Stroumbis CS, Elisaf MS, Sideris DA, Tselepis AD.
    J Cardiovasc Risk; 2001 Oct 05; 8(5):311-7. PubMed ID: 11702038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.